The Business Times
The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN
SUBSCRIBERS

Dengue cure: S'pore researchers move to next phase

SingHealth and Duke-NUS in exclusive licensing deal with US firm 60° Pharmaceuticals

Published Wed, Jul 30, 2014 · 10:00 PM
Share this article.

[SINGAPORE] Even as the world's first dengue vaccine is set to hit Singapore shores next year, reseachers here are one step closer to finding the first antiviral drug that treats the illness.

Researchers from the Singapore General Hospital and Duke-NUS Graduate Medical School completed a study called CELADEN last year that found Cel…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

New Articles

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here